Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pi-Vit is a dietary supplement formulated to support the physiological maintenance of the vitreous body in the eye. It contains a blend of BioCell Collagen (type II hydrolyzed collagen, chondroitin sulfate, hyaluronic acid), D-glucosamine, magnesium, grape seed extract from Vitis Vinifera L. (rich in proanthocyanidins), vitamin E, and vitamin B6. The supplement is designed to combat oxidative and degenerative changes affecting the vitreous body—such as floaters—by providing antioxidant protection and supporting connective tissue metabolism. Its ingredients are selected for their roles in cellular metabolism, antioxidation, and connective tissue health[1][9][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pi-vit.